Amazon Prime Air drones will fly into College Station later this year. Photo courtesy of Amazon

A Houston neighbor will be among the first in the nation to test pilot a game-changing delivery system. Amazon has announced plans to deploy its state-of-the art Prime Air drone delivery in College Station, Texas later this year.

The online juggernaut is already reaching out to College Station customers, telling them that they’ll soon receive free and fast drone delivery on thousands of everyday items. The deployment marks the largest selection of items to ever be available for drone delivery, per Amazon. College Station joins Lockeford, California as targeted test sites for drone launch.

“We are impressed with so many aspects of College Station,” notes an Amazon blog post announcing the news. “The innovative research conducted by Texas A&M University, the small-town feel, and the sense of community that is clear from the minute you arrive in town all make it a very special place.”

Jeff Bezos’ empire plans to also collaborate with the Aggies on tech. “We are thrilled about the opportunity to launch this service in College Station and partner with the city and its world-class university on some of the great work they’ve been doing in the area drone technology,” the post adds.

How will it work? Once onboarded, College Station customers can then view Prime Air-eligible items on Amazon, where they can place orders and receive an estimated arrival time with a status tracker for their order.

Amazon Prime Air’s New Delivery Dronewww.youtube.com

Drones will then fly to the designated delivery location, descend to the customer’s backyard, and hover at a safe height. The drones will then safely release the package, rise back up to altitude, and return to base, per Amazon.

Amazon is touting the difference of its drone fleet versus the masses. Prime Air drones fly up to 50 miles per hour, up to an altitude of 400 feet, and carry packages of up to 5 pounds.

Unlike most drones, Amazon notes, Prime Air drones utilize a sophisticated, sense-and-avoid system allowing them to operate at greater distances while safely and reliably avoiding other aircraft, people, pets, and obstacles. That means the drones can identify objects such as aircraft, birds, or static places such as trees and chimneys, avoid them, and select a safe space to land and later, safely leave.

“Being one of the first drone delivery locations for Amazon puts College Station at the forefront of this exciting technology,” said John Sharp, chancellor of The Texas A&M University System, in a statement. “What happens here will help advance drone delivery for the rest of the country and perhaps the rest of the world. We welcome Amazon to our community and stand ready to assist however we can.”

College Station, Amazon promises, will benefit by more than just speedy, environmentally friendly delivery. “We’re bringing more than drone delivery to Lockeford and College Station,” notes the Amazon blog. “Through these Prime Air drone deliveries, we will create new jobs, build partnerships with local organizations, and help to reduce the impact of climate change on future generations.”

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.